These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17316567)

  • 1. Semliki Forest virus vectors expressing transforming growth factor beta inhibit experimental autoimmune encephalomyelitis in Balb/c mice.
    Vähä-Koskela MJ; Kuusinen TI; Holmlund-Hampf JC; Furu PT; Heikkilä JE; Hinkkanen AE
    Biochem Biophys Res Commun; 2007 Apr; 355(3):776-81. PubMed ID: 17316567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental autoimmune encephalomyelitis with a neurotropic alphavirus vector expressing tissue inhibitor of metalloproteinase-2.
    Nygårdas PT; Grönberg SA; Heikkilä J; Joronen K; Sorsa T; Hinkkanen AE
    Scand J Immunol; 2004 Oct; 60(4):372-81. PubMed ID: 15379862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-4 is the key regulator in herpes simplex virus-based gene therapy of BALB/c experimental autoimmune encephalomyelitis.
    Broberg EK; Salmi AA; Hukkanen V
    Neurosci Lett; 2004 Jul; 364(3):173-8. PubMed ID: 15196670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) inhibits experimental autoimmune encephalomyelitis in dark Agouti (DA) rats.
    Zhu CS; Hu XQ; Xiong ZJ; Lu ZQ; Zhou GY; Wang DJ
    Life Sci; 2008 Sep; 83(11-12):404-12. PubMed ID: 18721816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector.
    Smyth JW; Fleeton MN; Sheahan BJ; Atkins GJ
    Gene Ther; 2005 Jan; 12(2):147-59. PubMed ID: 15372069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of Semliki Forest virus infection in the mouse central nervous system.
    Donnelly SM; Sheahan BJ; Atkins GJ
    Neuropathol Appl Neurobiol; 1997 Jun; 23(3):235-41. PubMed ID: 9223133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
    Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5.
    Nygårdas M; Aspelin C; Paavilainen H; Röyttä M; Waris M; Hukkanen V
    Gene Ther; 2011 Jul; 18(7):646-55. PubMed ID: 21326329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Smad7, a negative regulator of TGF-beta signaling, suppresses autoimmune encephalomyelitis.
    Kleiter I; Pedré X; Mueller AM; Poeschl P; Couillard-Despres S; Spruss T; Bogdahn U; Giegerich G; Steinbrecher A
    J Neuroimmunol; 2007 Jul; 187(1-2):61-73. PubMed ID: 17553571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNS gene therapy applications of the Semliki Forest virus 1 vector are limited by neurotoxicity.
    Graham A; Walker R; Baird P; Hahn CN; Fazakerley JK
    Mol Ther; 2006 Mar; 13(3):631-5. PubMed ID: 16423561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens.
    Smith ML; Corbo T; Bernales J; Lindbo JA; Pogue GP; Palmer KE; McCormick AA
    Virology; 2007 Feb; 358(2):321-33. PubMed ID: 17014881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and expression of murine IFN beta and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis.
    Triantaphyllopoulos K; Croxford J; Baker D; Chernajovsky Y
    Gene Ther; 1998 Feb; 5(2):253-63. PubMed ID: 9578846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice.
    Lyons JA; Sheahan BJ; Galbraith SE; Mehra R; Atkins GJ; Fleeton MN
    Gene Ther; 2007 Mar; 14(6):503-13. PubMed ID: 17167497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis.
    Jerusalmi A; Morris-Downes MM; Sheahan BJ; Atkins GJ
    Mol Ther; 2003 Dec; 8(6):886-94. PubMed ID: 14664790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
    Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
    PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semliki Forest virus vectors expressing the H and HN genes of measles and mumps viruses reduce immunity induced by the envelope protein genes of rubella virus.
    Callagy SJ; Kelly BJ; Fleeton MN; Sheahan BJ; Galbraith SE; Atkins GJ
    Vaccine; 2007 Oct; 25(43):7481-90. PubMed ID: 17905485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier breakdown and increased intercellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest (A7) virus infection facilitates the development of experimental allergic encephalomyelitis.
    Erälinna JP; Soilu-Hänninen M; Röyttä M; Hukkanen V; Salmi AA; Salonen R
    J Neuroimmunol; 1996 May; 66(1-2):103-14. PubMed ID: 8964903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta as a promising option in the treatment of multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Neuropharmacology; 2009; 56(6-7):929-36. PubMed ID: 19285095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas.
    Rodriguez-Madoz JR; Prieto J; Smerdou C
    Mol Ther; 2005 Jul; 12(1):153-63. PubMed ID: 15963931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.